IBDEI25U ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36648,1,4,0)
 ;;=4^M05.10
 ;;^UTILITY(U,$J,358.3,36648,2)
 ;;=^5009862
 ;;^UTILITY(U,$J,358.3,36649,0)
 ;;=D86.86^^137^1768^42
 ;;^UTILITY(U,$J,358.3,36649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36649,1,3,0)
 ;;=3^Sarcoid Arthropathy
 ;;^UTILITY(U,$J,358.3,36649,1,4,0)
 ;;=4^D86.86
 ;;^UTILITY(U,$J,358.3,36649,2)
 ;;=^5002451
 ;;^UTILITY(U,$J,358.3,36650,0)
 ;;=D86.83^^137^1768^43
 ;;^UTILITY(U,$J,358.3,36650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36650,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,36650,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,36650,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,36651,0)
 ;;=D86.81^^137^1768^44
 ;;^UTILITY(U,$J,358.3,36651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36651,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,36651,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,36651,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,36652,0)
 ;;=D86.85^^137^1768^45
 ;;^UTILITY(U,$J,358.3,36652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36652,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,36652,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,36652,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,36653,0)
 ;;=D86.87^^137^1768^46
 ;;^UTILITY(U,$J,358.3,36653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36653,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,36653,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,36653,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,36654,0)
 ;;=D86.84^^137^1768^47
 ;;^UTILITY(U,$J,358.3,36654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36654,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,36654,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,36654,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,36655,0)
 ;;=D86.0^^137^1768^48
 ;;^UTILITY(U,$J,358.3,36655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36655,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,36655,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,36655,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,36656,0)
 ;;=D86.2^^137^1768^49
 ;;^UTILITY(U,$J,358.3,36656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36656,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,36656,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,36656,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,36657,0)
 ;;=D86.1^^137^1768^50
 ;;^UTILITY(U,$J,358.3,36657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36657,1,3,0)
 ;;=3^Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,36657,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,36657,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,36658,0)
 ;;=D86.89^^137^1768^51
 ;;^UTILITY(U,$J,358.3,36658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36658,1,3,0)
 ;;=3^Sarcoidosis of Oth Sites
 ;;^UTILITY(U,$J,358.3,36658,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,36658,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,36659,0)
 ;;=D86.3^^137^1768^52
 ;;^UTILITY(U,$J,358.3,36659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36659,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,36659,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,36659,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,36660,0)
 ;;=D86.9^^137^1768^53
 ;;^UTILITY(U,$J,358.3,36660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36660,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,36660,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,36660,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,36661,0)
 ;;=M35.01^^137^1768^54
 ;;^UTILITY(U,$J,358.3,36661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36661,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,36661,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,36661,2)
 ;;=^5011787
